Drug
Arv 110
Arv 110: highest development phase Phase 1/2, developed by Arvinas. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1/2
- Developer
- Arvinas
Trials
| Drug | Phase | Indication |
|---|---|---|
| ARV-110 NCT03888612 | Phase 1/2 | Prostate Cancer Metastatic |
Latest
No recent events.
Follow Arv 110 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.